Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings.

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel Education.                    

*Date:*                         January 25, 2011.                    

*Time:*                         3 p.m. to 4:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hilton Washington/Rockville, 1750 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Timothy C. Meeker, M.D., PhD, Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279.                         *meekert@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. SPORE in Glioma, Head and Neck, Lymphoma, Myeloid Leukemia, and Myeloma.                    

*Date:*                         February 2-3, 2011.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Shamala K. Srinivas, PhD, Scientific Review Officer, Research Programs Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 8123, Bethesda, MD 20892. 301-594-1224.                         *ss537t@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Alternative Biospecimen Stabilization and Storage Solutions.                    

*Date:*                         March 10, 2011.                    

*Time:*                         1 p.m. to 3 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         National Institutes of Health, 6116 Executive Boulevard, Room 706, Rockville, MD 20852. (Telephone Conference Call).                    

*Contact Person:*                         Donald L. Coppock, PhD, Scientific Review Officer, Scientific Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm. 7151, Bethesda, MD 20892. 301-451-9385.                         *donald.coppock@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel, In vivo Cellular and Molecular Imaging Centers (ICMICs).                    

*Date:*                         March 15-16, 2011.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Gaithersburg Hilton, 620 Perry Parkway, Gaithersburg, MD 20877.                    

*Contact Person:*                         Kenneth L. Bielat, PhD, Scientific Review Officer, Special Review Logistics Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard, Room 7147, Bethesda, MD 20892-8329. 301-496-7576.                         *bielatk@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Development of Devices for Point of Care Analysis of Circulating Tumor Cells.                    

*Date:*                         March 17-18, 2011.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Doubletree Hotel Bethesda, (Formerly Holiday Inn Select) 8120 Wisconsin Avenue, Bethesda, MD 20814.                    

*Contact Person:*                         Donald L. Coppock, PhD, Scientific Review Officer, Scientific Review and Logistic Branch, Division of Extramural Activities, NCI, National Institutes of Health, 6116 Executive Blvd., Rm. 7151, Bethesda, MD 20892. 301-451-9385.                         *donald.coppock@nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Development of Anticancer Agents.                    

*Date:*                         March 23-25, 2011.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate contract proposals.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329. 301-594-1286.                         *peguesj@mail.nih.gov.*

*Name of Committee:*                         National Cancer Institute Special Emphasis Panel. Small Grants Program for Cancer Epidemiology.                    

*Date:*                         April 28-29, 2011.                    

*Time:*                         8:30 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Legacy Hotel and Meeting Center, 1775 Rockville Pike, Rockville, MD 20852.                    

*Contact Person:*                         Joyce C. Pegues, B.S., B.A., PhD, Scientific Review Officer, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Boulevard, Room 7149, Bethesda, MD 20892-8329. 301-594-1286.                         *peguesj@mail.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)

Dated: December 13, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-31733 Filed 12-16-10; 8:45 am]

BILLING CODE 4140-01-P